SOST and Miyoshi myopathy: We propose thatinhibition of Sclerostin with antibody or alternativemethods may prevent bone lesion in MM patientswith the best result (without or at least side effect).However, it is strongly recommended that this antibody or other alternative procedure like epigeneticprocedures are first done on animal models beforeon MM patients.